Overview
Dora Romaguera practices in Palma, Spain. Ms. Romaguera is highly rated in 5 conditions, according to our data. Her top areas of expertise are Metabolic Syndrome, Obesity, Abdominal Obesity Metabolic Syndrome, and Type 2 Diabetes (T2D).
Her clinical research consists of co-authoring 298 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Metabolic SyndromeMs. Romaguera isElite. Learn about Metabolic Syndrome.
- Distinguished
- Abdominal Obesity Metabolic SyndromeMs. Romaguera isDistinguished. Learn about Abdominal Obesity Metabolic Syndrome.
- ObesityMs. Romaguera isDistinguished. Learn about Obesity.
- Advanced
- Maturity Onset Diabetes of the YoungMs. Romaguera isAdvanced. Learn about Maturity Onset Diabetes of the Young.
- Type 2 Diabetes (T2D)Ms. Romaguera isAdvanced. Learn about Type 2 Diabetes (T2D).
- Experienced
- ArthritisMs. Romaguera isExperienced. Learn about Arthritis.
- AtherosclerosisMs. Romaguera isExperienced. Learn about Atherosclerosis.
- Atrial FibrillationMs. Romaguera isExperienced. Learn about Atrial Fibrillation.
- Attention Deficit Hyperactivity Disorder (ADHD)
- Breast CancerMs. Romaguera isExperienced. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Ms. Romaguera isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).